Nuvation Bio, Inc. (PANA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

bluebird bio, Inc.

Nuvation Bio, Inc.

MaxCyte, Inc.

uniQure NV

Humacyte, Inc.

23andMe Holding Co.

MeiraGTx Holdings Plc

Terns Pharmaceuticals, Inc.

Aura Biosciences, Inc.

Zura Bio Ltd.

Renovaro, Inc.

Why is Nuvation Bio, Inc. ?

The company has declared Negative results for the last 4 consecutive quarters

INTEREST(HY) At USD 0.47 MM has Grown at 259.85%
OPERATING CASH FLOW(Y) Lowest at USD -168.19 MM
OPERATING PROFIT(Q) Lowest at USD -63.23 MM

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 208.58%, its profits have fallen by -167.3%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nuvation Bio, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nuvation Bio, Inc.

221.93%

1.92

96.62%

S&P 500

12.65%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

97.97%

EBIT Growth (5y)

-232.77%

EBIT to Interest (avg)

-104.57

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.08

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

76.02%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.01

EV to EBIT

-1.89

EV to EBITDA

-1.90

EV to Capital Employed

-11.25

EV to Sales

35.57

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-43.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

NET SALES(HY)

Higher at USD 7.92 MM

NET PROFIT(HY)

Higher at USD -111.95 MM

RAW MATERIAL COST(Y)

Fallen by -422.91% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 41.48 times

DEBTORS TURNOVER RATIO(HY)

Highest at 2.69 times

-30What is not working for the Company

INTEREST(HY)

At USD 0.47 MM has Grown at 259.85%

OPERATING CASH FLOW(Y)

Lowest at USD -168.19 MM

OPERATING PROFIT(Q)

Lowest at USD -63.23 MM

PRE-TAX PROFIT(Q)

Lowest at USD -59.46 MM

NET PROFIT(Q)

Lowest at USD -59.46 MM

Here's what is working for Nuvation Bio, Inc.

Net Sales

At USD 7.92 MM has Grown at 451.71%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Net Sales

Higher at USD 7.92 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Inventory Turnover Ratio

Highest at 41.48 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 2.69 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -422.91% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nuvation Bio, Inc.

Interest

At USD 0.47 MM has Grown at 259.85%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit

At USD -59.46 MM has Fallen at -54.22%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -59.46 MM has Fallen at -54.22%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -168.19 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit

Lowest at USD -63.23 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -59.46 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -59.46 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)